SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-098760
Filing Date
2024-11-15
Accepted
2024-11-15 09:14:22
Documents
57
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0221219-10q_ostherap.htm   iXBRL 10-Q 865178
2 CERTIFICATION ea022121901ex31-1_ostherap.htm EX-31.1 7309
3 CERTIFICATION ea022121901ex31-2_ostherap.htm EX-31.2 7455
4 CERTIFICATION ea022121901ex32_ostherap.htm EX-32 6145
  Complete submission text file 0001213900-24-098760.txt   4820423

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE osti-20240930.xsd EX-101.SCH 57404
6 XBRL CALCULATION FILE osti-20240930_cal.xml EX-101.CAL 25605
7 XBRL DEFINITION FILE osti-20240930_def.xml EX-101.DEF 217899
8 XBRL LABEL FILE osti-20240930_lab.xml EX-101.LAB 436671
9 XBRL PRESENTATION FILE osti-20240930_pre.xml EX-101.PRE 239148
60 EXTRACTED XBRL INSTANCE DOCUMENT ea0221219-10q_ostherap_htm.xml XML 583964
Mailing Address 15825 SHADY GROVE ROAD SUITE 135 ROCKVILLE MD 20850
Business Address 15825 SHADY GROVE ROAD SUITE 135 ROCKVILLE MD 20850 410-297-7793
OS Therapies Inc (Filer) CIK: 0001795091 (see all company filings)

IRS No.: 825118368 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42195 | Film No.: 241466020
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)